The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Metabolic Enzymes as Oncogenes or Tumor Suppressors
Open accessAbstract
Whether mutations in metabolic pathways contribute to the pathogenesis of cancer is controversial.1,2 Cancer cells have long been noted to preferentially metabolize glucose through glycolysis, a discovery that has been translated to the clinic through positron-emission-tomography imaging of 18F-deoxyglucose uptake in tumors. Moreover, recent studies have uncovered recurrent somatic mutations in four genes involved in the metabolism of mitochondrial citrate that either cause or predispose cells to become malignant.In this issue of the Journal, Yan and colleagues3 report that 70% or more of low-grade gliomas bear mutations in one of two NADP+-dependent isocitrate dehydrogenase enzymes (IDH1 and . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently it has become apparent that cancer is also associated with metabolic mutations confined to the tumor. In these diseases, the metabolic enzymes behave genetically as oncogenes or tumor suppressors (Figure 3A) (Frezza et al., 2011a; Thompson, 2009).”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Thompson, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Self-citationAnalysis of the IDH1 codon 132 mutation in brain tumors
Balss, J., Meyer, J., Mueller, W., Korshunov, A., Hartmann, C., & von Deimling, A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0455-2 · Cited by 1,036
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672
Xu, X., Zhao, J., Xu, Z., Peng, B., Huang, Q., Arnold, E., & Ding, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404298200 · Cited by 407
MacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359
Gasparre, G., Porcelli, A. M., Bonora, E., Pennisi, L. F., Toller, M., Iommarini, L., Ghelli, A. M., Moretti, M., Betts, C. M., Martinelli, G. N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703056104 · Cited by 316
Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle
Hartong, D. T., Dange, M., McGee, T. L., Berson, E. L., Dryja, T. P., & Colman, R. F. (2008) · Nature Genetics · doi:10.1038/ng.223 · Cited by 172
Lee, J. K., Edderkaoui, M., Truong, P. A., Ohno, I., Jang, K., Berti, A., Pandol, S. J., & Gukovskaya, A. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.022 · Cited by 157
Research works printed but not linked: 1
- 10.1056/NEJMoa0808710 · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 215
Xiao, J., Howard, L. E., Wan, J., Wiggins, E. K., Vidal, A. C., Cohen, P., & Freedland, S. J. (2017) · Oncotarget · doi:10.18632/oncotarget.20134 · Cited by 39
Correlation between IDH1 gene mutation status and survival of patients treated for recurrent glioma.
Lv, S., Teugels, E., Sadones, J., Quartier, E., Huylebrouck, M., Four, S. D., Mercier, M. L., Witte, O. D., Salmon, I. J., Michotte, A., et al. (2011) · PubMed · Cited by 37
Facile Synthesis [5-13C-4-2H2]-L-Glutamine for Hyperpolarized MRS Imaging of Cancer Cell Metabolism
Qü, W., Zha, Z., Lieberman, B. P., Mancuso, A., Stetz, M., Rizzi, R., Plöessl, K., Wise, D. R., Thompson, C. B., & Kung, H. F. (2011) · Academic Radiology · doi:10.1016/j.acra.2011.05.002 · Cited by 37
Self-citationIn vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.
Anderson, K. M., Jajeh, J., Guinan, P., & Rubenstein, M. (2009) · PubMed · Cited by 37
Das, F., Bera, A., Ghosh‐Choudhury, N., Abboud, H. E., Kasinath, B. S., & Choudhury, G. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109608 · Cited by 37
Zhang, L., Miao, X., Wang, X., Pan, H., Li, P., Ren, H., Jia, Y., Lu, C., Wang, H., Yuan, L., et al. (2016) · Scientific Reports · doi:10.1038/srep28116 · Cited by 35
Biomarker signatures of mitochondrial NDUFS3 in invasive breast carcinoma
Suhane, S., Berel, D., & Ramanujan, V. K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.003 · Cited by 35
Xu, H. N., Zheng, G., Tchou, J. C., Nioka, S., & Li, L. Z. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-73 · Cited by 33
NADP+-dependent IDH1R132 mutation and its relevance for glioma patient survival
Tewarie, N. M. S. B., Burgers, I. A. V., Dawood, Y., den Boon, H. C., den Brok, M. G. H. E., Klunder, J. H., Koopmans, K. B., Rademaker, E., van den Broek, H. B., van den Bersselaar, S. M., et al. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.02.022 · Cited by 33
Heiland, D. H., Gaebelein, A., Börries, M., Wörner, J., Pompe, N., Franco, P., Heynckes, S., Bartholomae, M., hAilín, D. Ó., Carro, M. S., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0680 · Cited by 34
Survival of the fittest: metabolic adaptations in cancer
Berardi, M. J., & Fantin, V. R. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.001 · Cited by 30
Atai, N. A., Renkema-Mills, N. A., Bosman, J., Schmidt, N., Rijkeboer, D., Tigchelaar, W., Bosch, K. S., Troost, D., Jonker, A., Bleeker, F. E., et al. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411400606 · Cited by 32
Imaging mitochondrial redox potential and its possible link to tumor metastatic potential
Li, L. Z. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9469-5 · Cited by 32
Kuo, C., Cheng, C.-T., Hou, P., Lin, Y.-P., Ma, H., Chung, Y., Chi, K. K., Chen, Y., Li, W., Kung, H.-J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8570 · Cited by 32
Curative role of pantothenic acid in brain damage of gamma irradiated rats
Shedid, S. M., Saada, H. N., Na, E., & Hammad, A. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0683-0 · Cited by 30
Oncometabolites and the response to radiotherapy
Xiang, K., Jendrossek, V., & Matschke, J. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01638-9 · Cited by 30
Dual role of Nrf2 in cancer: molecular mechanisms, cellular functions and therapeutic interventions
Poornashree, M., Kumar, H., AJMEER, R., Jain, R., & Jain, V. K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08126-1 · Cited by 28
The Multifaceted Metabolism of Glioblastoma
Quinones, A., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_4 · Cited by 28
Galina, A. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.013 · Cited by 30
Glucose Metabolism Gene Variants Modulate the Risk of Pancreatic Cancer
Dong, X., Li, Y., Chang, P., Tang, H., Hess, K. R., Abbruzzese, J. L., & Li, D. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0247 · Cited by 27
Mitochondria: a new intervention target for tumor invasion and metastasis
Zhou, Q., Cao, T., Li, F., Zhang, M., Li, X., Zhao, H., & Zhou, Y. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00899-4 · Cited by 26
The Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis
Nazar, E., Khatami, F., Saffar, H., & Tavangar, S. M. (2019) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v13i2.692 · Cited by 26
Cancer plasticity: Investigating the causes for this agility
Saha, S., Pradhan, N., Neha, B., Mahadevappa, R., Minocha, S., & Kumar, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.005 · Cited by 27
The Multifaceted Glioblastoma: From Genomic Alterations to Metabolic Adaptations
Quinones, A., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_4 · Cited by 25
Manley, S., Liu, W., & Welch, D. R. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1552-2 · Cited by 26
Heterogeneity of the cancer cell line metabolic landscape
Shorthouse, D., Bradley, J., Critchlow, S. E., Bendtsen, C., & Hall, B. A. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211006 · Cited by 24
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs
Cimini, A., d’Angelo, M., Benedetti, E., D’Angelo, B., Laurenti, G., Antonosante, A., Cristiano, L., Mambro, A. D., Barbarino, M., Castelli, V., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25421 · Cited by 22
IDH2 mutation in gliomas including novel mutation
Koh, J., Cho, H.-J., Kim, H., Kim, S. I., Yun, S., Park, C., Lee, S., Choi, S. H., & Park, S. (2014) · Neuropathology · doi:10.1111/neup.12187 · Cited by 23
Brown Adipose Transplantation Improves Polycystic Ovary Syndrome-Involved Metabolome Remodeling
Yao, L., Wang, Q., Zhang, R., Wang, X., Liu, Y., Di, F., Song, L., & Xu, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.747944 · Cited by 21
Pan, Y., Luan, X., Gao, Y., Zeng, F., Wang, X., Zhou, D., Li, W., Wang, Y., He, B., & Song, Y. (2023) · ACS Nano · doi:10.1021/acsnano.2c10453 · Cited by 21
Guo, X., Li, D., Wu, Y., Chen, Y., Zhou, X., Wang, X., Huang, X., Li, X., Yang, H., & Xing, J. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.12.005 · Cited by 23
Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor
Carpentieri, A., Cozzoli, E., Scimeca, M., Bonanno, E., Sardanelli, A. M., & Gambacurta, A. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.244 · Cited by 22
Metabolism and cancer: an up-to-date review of a mutual connection.
Mentis, A. A., & Kararizou, E. G. (2010) · PubMed · Cited by 20
Metabolomics of cancer cell cultures to assess the effects of dietary phytochemicals
Brasili, E., & Filho, V. C. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.964799 · Cited by 20
Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver
Liu, S., & Tao, Y. (2016) · 癌症:英文版 · doi:10.1186/s40880-016-0138-7 · Cited by 20
Hypoxia-induced mediators and neurologic disease
Benarroch, E. E. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b2a719 · Cited by 20
Glioma-derived mutations in isocitrate dehydrogenase 2 beneficial to traditional chemotherapy
Fu, Y., Huang, R., Zheng, Y., Zhang, Z., & Liang, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.108 · Cited by 19
Grelli, K. N., Palubinsky, A. M., Kale, A. C., Lizama, B. N., Stankowski, J. N., Milne, G. L., Singer, R. J., & McLaughlin, B. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113129990062 · Cited by 18
The Pulmonary Toxicity of Anticancer Agents
Yoneda, K. Y., & Cross, C. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00924-6 · Cited by 19
TNFAIP8 drives metabolic reprogramming to promote prostate cancer cell proliferation
Niture, S. K., Lin, M., Odera, J. O., Moore, J. T., Zhe, H., Chen, X. L., Suy, S., Collins, S. P., & Kumar, D. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105885 · Cited by 16
Metabolic Plasticity in Cancer Cells: Reconnecting Mitochondrial Function to Cancer Control
Ramanujan, V. K. (2015) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000211 · Cited by 16
Liu, X., Liu, H., Zeng, L., & Lv, Y. (2022) · PeerJ · doi:10.7717/peerj.14052 · Cited by 16
Marine Compounds, Mitochondria, and Malignancy: A Therapeutic Nexus
Fakhri, S., Abdian, S., Moradi, S. Z., Delgadillo, B. E., Fimognari, C., & Bishayee, A. (2022) · Marine Drugs · doi:10.3390/md20100625 · Cited by 17
Jiang, H., Ren, X., Wang, J., Zhang, Z., Jia, W., & Lin, S. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1311-3 · Cited by 15
Acquaviva, G., Visani, M., de Biase, D., Marucci, G., Franceschi, E., Tosoni, A., Brandes, A. A., Rhoden, K. J., Pession, A., & Tallini, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-22222-y · Cited by 14
Mitochondrial Dysfunction and Morphological Abnormality in Keloid Fibroblasts
Li, Q., Qin, Z., Chen, B., An, Y., Nie, F., Yang, X., Pan, B., & Bi, H. (2019) · Advances in Wound Care · doi:10.1089/wound.2019.0988 · Cited by 13
Kolybaba, A. M., & Classen, A.-K. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1824-x · Cited by 14
Bao, X., Wu, J., Shuch, B. M., LoRusso, P. M., Bindra, R. S., & Li, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-47669-5 · Cited by 13
The Distribution and Significance of IDH Mutations in Gliomas
Mellai, M., Caldera, V., Annovazzi, L., & Schiffer, D. (2013) · InTech eBooks · doi:10.5772/52357 · Cited by 14
Yang, Q., Yan, R., Zhang, J., Zhang, T., Kong, Q., Zhang, X., Xia, H., Ye, A., Qiao, X., Kato, K., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.165207 · Cited by 11
Tumor Metabolism: A New Field for the Treatment of Glioma
Chai, X., Zhang, Y., Zhang, W., Feng, K., Jiang, Y., Zhu, A., Chen, X., Di, L., & Wang, R. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00287 · Cited by 10
Chen, A., Xu, M., Chen, J., Chen, T., Wang, Q., Zhang, R., & Qiu, J. (2022) · BioMed Research International · doi:10.1155/2022/6207701 · Cited by 10
Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis
Lee, W., Chou, H., Wu, T.-J., Lee, C., Hsu, P., Hsu, H.-Y., Wu, T., & Chan, K. (2017) · Clinical Proteomics · doi:10.1186/s12014-017-9164-y · Cited by 10
Synthesis and preliminary evaluation of a novel glutamine derivative: (2S,4S)4-[18F]FEBGln
Huang, Y., Liu, S., Wu, R., Zhang, L., Zhang, Y., Hong, H., Zhang, A., Xiao, H., Liu, Y., Wu, Z., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.03.012 · Cited by 10
Cancer-associated isocitrate dehydrogenase mutations induce mitochondrial DNA instability
Kingsbury, J. M., Shamaprasad, N., Billmyre, R. B., Heitman, J., & Cardenas, M. E. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw195 · Cited by 10
Integrative Omics Analysis Reveals Metabolic Features of Ground-Glass Opacity-Associated Lung Cancer
Shi, S., Luo, D., Yang, Y., & Wang, X. (2024) · Journal of Cancer · doi:10.7150/jca.92437 · Cited by 9
Lu, Y., Du, N., Fang, X., Shu, W., Liu, W., Xu, X., Yao, Y., Li, X., Mao, R., Li, K., et al. (2024) · Cancer Imaging · doi:10.1186/s40644-024-00726-3 · Cited by 8
Unraveling the Complex Regulatory Relationships Between Metabolism and Signal Transduction in Cancer
Wynn, M. L., Merajver, S. D., & Schnell, S. D. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7210-1_9 · Cited by 9
Franceschi, E., de Biase, D., Nunno, V. D., Pession, A., Tosoni, A., Gatto, L., Lodi, R., Tallini, G., Visani, M., Bartolini, S., et al. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153445 · Cited by 8
Microenvironmental Metabolites in the Intestine: Messengers between Health and Disease
Zaurito, A. E., & Tschurtschenthaler, M. (2022) · Metabolites · doi:10.3390/metabo12010046 · Cited by 8
How Molecular Testing Can Help (and Hurt) in the Workup of Gliomas
Clark, K., Voronovich, Z. A., & Horbinski, C. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpfo8iidnbij8y · Cited by 8
Peng, X., Zhao, H., Ye, L., Hou, F., Yi, Z., Ren, Y., Lu, L., Chen, F., Lv, J., Wang, Y., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3806 · Cited by 7
Salem, D., El-Aziz, S. A., El‐Menshawy, N., Abouzeid, T., & Ebrahim, M. (2016) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-016-0649-z · Cited by 7
Single-cell profiling of D-2-hydroxyglutarate using surface-immobilized resazurin analogs
Cheng, H., Li, Z., Guo, Z., Shao, S., Mo, L., Wei, W., & Xue, M. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113368 · Cited by 7
Feraco, P., Franciosi, R., Picori, L., Scalorbi, F., & Gagliardo, C. (2022) · Biomedicines · doi:10.3390/biomedicines10102490 · Cited by 7
Wallace, D. C., Lott, M. T., & Procaccio, V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00013-6 · Cited by 8
Li, X.-P., He, L., Wang, Y., Li, Y., Li, M., & Peng, Y. (2014) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.06.014 · Cited by 7
Lactate detection in inducible and orthotopic Her2/neu mammary gland tumours in mouse models
Magnitsky, S. G., Belka, G. K., Sterner, C. J., Pickup, S., Chodosh, L. A., & Glickson, J. D. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2816 · Cited by 6
Li, L., Sun, H., BAI, Y., Gao, S.-P., Jiang, H., & Jin, W. (2016) · Neoplasma · doi:10.4149/neo_2016_408 · Cited by 6
Metabolic Reprogramming in Human Cancer Patients and Patient-Derived ModelsPreprint
Fan, T. W. ‐., Higashi, R. M., & Lane, A. N. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041552 · Cited by 7
Braun, M. M., Damjanac, T., Zhang, Y., Chen, C., Hu, J., & Maher, L. J., III (2019) · PLoS ONE · doi:10.1371/journal.pone.0227033 · Cited by 6
Mameri, H., Buhagiar‐Labarchède, G., Fontaine, G., Corcelle, C., Barette, C., Onclercq, R., Beauvineau, C., Mahuteau‐Betzer, F., & Amor-Guéret, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04487-9 · Cited by 5
Novel R218X mutation in the fumarate hydratase gene in a patient with Reed's syndrome
Akita, F., Kambe, N., Nakano, M., Satoh, T. K., Iwasawa, M., Togawa, Y., & Matsue, H. (2012) · The Journal of Dermatology · doi:10.1111/1346-8138.12002 · Cited by 5
Isocitrate dehydrogenase mutations in low-grade gliomas
Schiff, D., & Purow, B. W. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.57 · Cited by 5
Constans, J., Collet, S., Guillamo, J., Hossu, G., Lacombe, S., Gauduel, Y. A., Houée‐Levin, C., Dou, W., Ruan, S., Barré, L., et al. (2011) · Journal of Physics Conference Series · doi:10.1088/1742-6596/261/1/012011 · Cited by 5
Tumor biology as a basis for molecular targeting in cancer
Larson, S. M., Mariani, G., & Strausś, H. W. (2013) · Clinical and Translational Imaging · doi:10.1007/s40336-013-0044-9 · Cited by 4
Wang, H., Wang, X., Xu, L., & Zhang, J. (2023) · World Neurosurgery · doi:10.1016/j.wneu.2023.05.109 · Cited by 3
Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics
Mierke, C. T. (2020) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-030-58532-7_17 · Cited by 2
Xu, H. N., Kadlececk, S., Pullinger, B. D., Profka, H., Cai, K., Hariharan, H., Rizi, R. R., & Li, L. Z. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-7411-1_32 · Cited by 3
Zhenhong, Z. (2011) · African Journal of Microbiology Research · doi:10.5897/ajmr11.207 · Cited by 2
Metabolic Switch: A Phenotype or a Phenomenon?
Ramanujan, K., V (2014) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000161 · Cited by 1
Dico, A. L., Salvatore, D., Diceglie, C., Martelli, C., & Ottobrini, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00026-9 · Cited by 1
Cancer Biology of Molecular Imaging
Larson, S. M. (2022) · Springer eBooks · doi:10.1007/978-3-031-05494-5_1 · Cited by 1
Gordillo, G. M., & Sen, C. K. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7554-6_6 · Cited by 1
The Cancer Biology of Molecular Imaging
Larson, S. M. (2012) · Springer eBooks · doi:10.1007/978-0-387-48894-3_1
Molekulare Bildgebung in der Tumortherapie
Weber, W. (2011) · Der Onkologe · doi:10.1007/s00761-011-2043-7
Dong-feng, C. (2013) · Lund University Publications (Lund University)
Martz, L. (2012) · Science-Business eXchange · doi:10.1038/scibx.2012.513
Unravelling the connection between metabolism, cell growth and cancer
Draganescu, C., Jacobsen, L., Hindié, E., & Baillet, G. (2015) · Médecine Nucléaire · doi:10.1016/j.mednuc.2015.01.004
Martı́n-Castillo, B., Vázquez‐Martín, A., Oliveras‐Ferraros, C., & Menéndez, J. A. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)62003-0
Molekulare Bildgebung in der Tumortherapie
Weber, W. (2010) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-010-1092-1
Excellence in neurosurgical research: the neuro-oncology paradigm.
Rutka, J. T. (2010) · PubMed
Current state of the evolving MMMN cancer progression models of cancer
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.022
Designing a broad-spectrum integrative approach for cancer prevention and treatment
Heiden, M. G. V., & Matthew, G. (2015) · PMC
glioblastomas display improved survival and reduced NADP + -dependent IDH activity ex vivo
Atai, N., Lamba, S., Gravendeel, L. A. M., van Tilborg, A., Leenstra, S., Frattini, M., Martı́n, V., Jonker, A., Rijkeboer, D., Tigchelaar, W., et al. (2009)
Cancer Biology of Molecular Imaging
Larson, S. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-26067-9_1-1
Mitochondria Remodeling in Cancer
Dornfeld, K. J., & Skildum, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_9
Villarreal, B., & Nadilly, Y. (2021) · Figshare
Cancer Biology of Molecular Imaging
Larson, S. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-26236-9_1
Metadata
- Authors
- Thompson, C. B.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Thompson, Craig B.
- ORCID
- Thompson, Craig B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-02-19
- Volume
- 360
- Issue
- 8
- Pages
- 813-815
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2848669
- OpenAlex
- W2075033593
- Cited by
- 213
- References
- 12
- Citations by year
- 2026: 2 · 2024: 12 · 2023: 4 · 2022: 15 · 2021: 8 · 2020: 7 · 2019: 10 · 2018: 11 · 2017: 9 · 2016: 10 · 2015: 11 · 2014: 14 · 2013: 18 · 2012: 16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P01CA104838, R01CA092660, R01CA105463)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- metabolic enzymes, oncogenes, tumor suppressor, isocitrate dehydrogenase, IDH1, IDH2, low-grade glioma, somatic mutations, cancer metabolism, glycolysis
- MeSH terms
- Brain Neoplasms, DNA Mutational Analysis, Fumarate Hydratase, Glioblastoma, Glioma, Humans, Isocitrate Dehydrogenase, Mutation, Succinate Dehydrogenase, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review